Publicacións en colaboración con investigadores/as de Universidade Do Porto (21)

2021

  1. Erratum to “Paget´s disease of the male breast: An unusual case in a young man and literature review” [Current Problems in Cancer: Case Reports 1C (2020) 100019](S2666621920300193)(10.1016/j.cpccr.2020.100019)

    Current Problems in Cancer: Case Reports

2020

  1. BR-BCSC Signature: The Cancer Stem Cell Profile Enriched in Brain Metastases that Predicts a Worse Prognosis in Lymph Node-Positive Breast Cancer

    Cells, Vol. 9, Núm. 11

2017

  1. P-cadherin: A useful biomarker for axillary-based breast cancer decisions in the clinical practice

    Modern Pathology, Vol. 30, Núm. 5, pp. 698-709

  2. Prognostic value of stromal tumour infiltrating lymphocytes and programmed cell death-ligand 1 expression in breast cancer

    Journal of Clinical Pathology, Vol. 70, Núm. 10, pp. 860-867

2015

  1. Altered PPP2R2A and Cyclin D1 expression defines a subgroup of aggressive luminal-like breast cancer

    BMC Cancer, Vol. 15, Núm. 1

2013

  1. P-cadherin functional role is dependent on E-cadherin cellular context: A proof of concept using the breast cancer model

    Journal of Pathology, Vol. 229, Núm. 5, pp. 705-718

  2. Renal effects of levosimendan: A consensus report

    Cardiovascular Drugs and Therapy, Vol. 27, Núm. 6, pp. 581-590

2012

  1. Claudin expression in breast cancer: High or low, what to expect?

    Histology and Histopathology, Vol. 27, Núm. 10, pp. 1283-1295

  2. Immunohistochemical features of claudin-low intrinsic subtype in metaplastic breast carcinomas

    Breast, Vol. 21, Núm. 3, pp. 354-360

  3. P-cadherin is coexpressed with CD44 and CD49f and mediates stem cell properties in basal-like breast cancer

    Stem Cells, Vol. 30, Núm. 5, pp. 854-864

2011

  1. Breast cancer stem cell markers CD44, CD24 and ALDH1: Expression distribution within intrinsic molecular subtype

    Journal of Clinical Pathology, Vol. 64, Núm. 11, pp. 937-944

  2. Nottingham Prognostic Index in Triple-Negative Breast Cancer: A reliable prognostic tool?

    BMC Cancer, Vol. 11

2008

  1. Breast carcinomas that co-express E- and P-cadherin are associated with p120-catenin cytoplasmic localisation and poor patient survival

    Journal of Clinical Pathology, Vol. 61, Núm. 7, pp. 856-862

  2. Importance of TP53 codon 72 and intron 3 duplication 16bp polymorphisms in prediction of susceptibility on breast cancer

    BMC Cancer, Vol. 8

2007

  1. DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: A study on a Portuguese population

    Breast Cancer Research and Treatment, Vol. 103, Núm. 2, pp. 209-217

2006

  1. Concordance between undergraduate dental students and their lecturers in their attitudes towards difficult patients

    European Journal of Dental Education, Vol. 6, Núm. 4, pp. 141-146

  2. Medical chronobiology: Inheritance and cancer [5]

    Revista Clinica Espanola

2004

  1. Telomerase expression and proliferative activity suggest a stem cell role for thyroid solid cell nests

    Modern Pathology, Vol. 17, Núm. 7, pp. 819-826

2003

  1. Chronobiology and breast cancer [3]

    Breast Journal

2002

  1. Analysis of mutations in genes BRCA1 and BRCA2 among patients with breast and ovarian cancer in northern Portugal and Galicia

    Revista Clinica Espanola, Vol. 202, Núm. 5, pp. 259-263